NCT07583823
Elevated Rate Pacing of Cardiac Amyloidosis
At risk: Primary completion moved 31 days later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Primary and study completion pushed from Oct 10, 2026 to Nov 10, 2026
- Eligibility criteria expanded, about 9 words
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Kansas City Cardiomyopathy Questionnaire Score
Timeframe: Month 4
Composite of any cardiovascular event
Timeframe: Month 4
Arms and interventions
Elevated Pacemaker RateExperimental
CA clinic patients with pacemakers will receive a personalized pacing protocol individual to their height and left ventricular ejection fraction.
Other: Pacemaker Rate
Sites
1 site in 1 country
- University of MinnesotaMinneapolis, Minnesota, United States